NCT05074810 2026-01-12
RAMP203
Verastem, Inc.
Phase 1/2 Active not recruiting
Clinical Trials
4 trialsNCT04620330 2024-01-12
RAMP202
Verastem, Inc.
Phase 2 Completed
NCT02758587 2018-03-19
Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)
NHS Greater Glasgow and Clyde
Phase 1/2 Unknown
NCT01951690 2017-04-13
Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer
Verastem, Inc.
Phase 2 Completed